Shruthi Sriramkumar

6PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance.

|Jul 27, 2022
A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer.

Vaishnavi Muralikrishnan, Fang Fang, Tyler C Given

|May 26, 2021
LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer.

Samuel A Miller, Robert A Policastro, Shruthi Sriramkumar

|Feb 26, 2021
Bacterial-Driven Inflammation and Mutant BRAF Expression Combine to Promote Murine Colon Tumorigenesis That Is Sensitive to Immune Checkpoint Therapy.

Christina E DeStefano Shields, James R White, Liam Chung

|Aug 18, 2020
Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer.

Shruthi Sriramkumar, Timothy D Matthews, Ahmed H Ghobashi

|Nov 10, 2019
Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in PIK3CA-Mutant Colorectal Cancer.

Samuel A Miller, Robert A Policastro, Sudha S Savant

Pageof 1

Frequent Collaborators

5 joint publications

Heather M O'Hagan

2 joint publications

Gabriel E Zentner

2 joint publications

Kenneth P Nephew

1 joint publications

Sha Cao